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Abstract 
Interplanetary spaceflight, such as NASA’s proposed three-year mission to Mars, provides unique and novel challenges 
when compared with human spaceflight to date.  Extended distance and multi-year missions introduce new elements 
of operational complexity and additional risk.  These elements include: inability to resupply medications and 
consumables, inability to evacuate injured or ill crew, uncharted psychosocial conditions, and communication delays 
that create a requirement for some level of autonomous medical capability.  Because of these unique challenges, the 
approaches used in prior programs have limited application to a Mars mission. On a Mars mission, resource limitations 
will significantly constrain available medical capabilities, and require a paradigm shift in the approach to medical 
system design and risk mitigation for crew health.  To respond to this need for a new paradigm, the Exploration Medical 
Capability (ExMC) Element is assessing each Mars mission phase—transit, surface stay, rendezvous, extravehicular 
activity, and return—to identify and prioritize medical needs for the journey beyond low Earth orbit (LEO).  ExMC is 
addressing both planned medical operations, and unplanned contingency medical operations that meld clinical needs 
and research needs into a single system.  This assessment is being used to derive a gap analysis and studies to support 
meaningful medical capabilities trades.  These trades, in turn, allow the exploration medical system design to proceed 
from both a mission centric and ethics-based approach, and to manage the risks associated with the medical limitations 
inherent in an exploration class mission.   This paper outlines the conceptual drivers used to derive medical system and 
vehicle needs from an integrated vision of how medical care will be provided within this paradigm. 
 




NASA has over four decades of experience in 
human spaceflight. Since 1961, over 400 men and 
women have travelled into space, most into low Earth 
orbit (LEO).  In the Skylab, Shuttle-MIR, and 
International Space Station (ISS) programs, NASA 
developed an evidence base for human health in “long 
duration” missions of over three weeks[1]. Today, 
NASA is planning for missions of over three years. 
With such great distance and duration, Mars missions 
are completely outside the scope of NASA’s human 
spaceflight experience. As a result, we are developing 
new strategies that are not reliant on existing 
assumptions.   
 
The current model of ISS LEO operations depends 
on real-time communications, regular resupply 
capability, and the possibility of evacuation in the case 
of medical emergencies. For a Mars mission, the 
delivery of medical care must be re-imagined to allow 
scoping of a system that will support crew and mission 
needs in a remote and isolated environment.  The task 
of developing this new medical system rests with the 
Exploration Medical Capability (ExMC) element of 
NASA’s Human Research Program (HRP). 
 
HRP is tasked with decreasing the risks to human 
spaceflight through research investment.  Specifically 
the goals of HRP are “to provide human health and 
performance countermeasures, knowledge, 
technology, and tools to enable safe, reliable, and 
productive human space exploration.” [2].  To reach 
this goal and enable a human Mars mission presents a 
unique challenge that requires an applied research 
program.  This is different from other models of 
research and development in two ways.  First, an 
applied research program has a specific goal: to 
improve the operational capabilities crew have in a 
mission at some defined point in the future.  In order 
to meet that goal, a conceptual basis for research 
investments must be structured toward the desired 
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endpoint.  Second, an applied research program is 
unable to provide an ongoing commitment to specific 
lines of inquiry.  As new information is understood, the 
odds of success of a particular investment must be 
constantly weighed against other benefits and 
investments.  In the context of providing medical care 
in the face of unknown challenges in a new mission, 
this ever-shifting prioritization becomes manageable 
through a structured approach to risk and development. 
 
ExMC is the HRP element tasked with decreasing 
the medical risks in human spaceflight.  All HRP 
Elements interface with the Human System Risk Board 
(HSRB). This Board uses a Continuous Risk 
Management (CRM) framework for approximately 30 
risks identified by NASA as critical to enabling human 
spaceflight.  The HSRB and this process are described 
in detail elsewhere [3].  ExMC has traditionally been 
tasked with addressing a single HSRB risk:  
 
“Given that medical conditions/events will occur 
during human spaceflight missions, there is a 
possibility of adverse health outcomes & 
decrements in performance in mission and for long 
term health.” [2] 
 
To address this risk, ExMC charters research 
projects, funds technology development, and 
interfaces with intra- and extra-agency resources.  In 
2015, ExMC was restructured to update its research 
plan and to better align with agency operational goals. 
Today, ExMC is focused on the creation of a vehicle-
integrated medical system designed to meet 




In 2001, the Committee on Creating a Vision for 
Space Medicine During Travel Beyond Low Earth 
Orbit delivered a report to NASA entitled, Safe 
Passage: Astronaut Care for Exploration Missions [4].  
This committee acted on authority of the Institute of 
Medicine to: 1) Assess what is known about the effects 
of space travel on health; and 2) Suggest how health 
care during space travel might be approached.  The 
recommendations from this report formed the 
conceptual basis for the current workings of the HRP.  
In the fifteen years since Safe Passage was published, 
some of its recommendations have been implemented 
in LEO.  Much work remains to extend its vision to 
exploration through the merging of engineering 
requirements and medical priorities in the context of 
ongoing technological development.  
 
As Safe Passage suggests, NASA’s exploration 
goals will require a comprehensive health care system 
built on a strategic research plan.  The Safe Passage 
Report is organized into seven chapters that each offer 
key conclusions with recommendation. Chapters 2 and 
6 are of particular significance to the conceptual 
drivers for an exploration medical system. All of the 
key elements in the committee’s recommendation are 
listed in Figure 1. 
 
 
Figure 1: Recommendations for a Human Centric 
forward path from the Institute of Medicine report Safe 
Passage. 
Some specific observations from Safe Passage bear 
note: 
 
From Conclusion 2: 
“Currently, there is no comprehensive and 
inclusive strategy to provide optimum health care for 
astronauts in support of long-duration missions 
beyond low Earth orbit, nor is there sufficient 
coordination of health care needs with the engineering 
aspects of such missions.” 
 
From Conclusion 6: 
“The human being must be integrated into the 
space mission in the same way in which all other 
aspects of the mission are integrated.”  
 
NASA has made a number of strides towards 
rectifying these issues since Safe Passage was 
published.  Planning for a Mars mission makes solving 
them more critical. 
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In 2006, the National Research Council published 
A Risk Reduction Strategy for Human Exploration of 
Space: A Review of NASA's Bioastronautics Roadmap 
[5]. The NRC identified Human Systems Integration as 
cross-cutting risk for all planned design reference 
missions: a year-long mission to ISS; a month-long 
mission to the moon; and a 30 month mission to Mars.  
The first one year mission to the ISS was recently 
completed. With the operational end of the 
International Space Station (ISS) in sight, the first test 
flight of Orion EM-1 behind us, and exploration 
groups architecting proving ground vehicles Mars 
focus systems and integration [6], the appropriate time 
to respond more fully to the vision of Safe Passage is 
now. 
 
Recommendation 2 in Safe Passage called for 
NASA to develop a comprehensive health care 
program for astronauts that will allow NASA to collect 
and analyze data necessary to support human 
spaceflight.  Achieving this goal requires the 
integration of exercise and performance information as 
well as environmental monitoring into the crew health 
system.  Integration of health information into the 
larger health system over time normalizes the data 
collection and handling needs for future systems. 
Recommendation 4 from Safe Passage also highlighted 
the need for behavioral health and other system 
monitoring and integration with the larger medical 
system.  
 
NASA responded to Safe Passage 
Recommendation 5 with the Lifetime Surveillance of 
Astronaut Health (LSAH) [7] Program and the 
formalization of occupational surveillance through a 
thorough occupational health model that collects and 
analyses a range of pertinent medical information.  
This occupational surveillance system provides much 
of the evidence base for improving our understanding 
of space related medical events as well as a contextual 
understanding of research data from other areas 
including the Life Sciences Data Archive (LSDA) [8].  
The LSDA is a database that includes evidence base 
records from spaceflight missions, analogs, and 
epidemiology from terrestrial medicine. As we enter 
the age of genomics and personalized medicine, the 
centralization and enrichment of data for more 
comprehensive analysis will present an ongoing 
challenge. 
 
Technology has significantly changed and evolved 
since the the ISS was designed, driving advances in 
medicine and in data systems. Computing power—
following Moore’s law—has grown exponentially 
smaller and more powerful, reducing the mass, 
volume, and power required to enable substantial 
processing capability that was not imaginable when 
construction on the ISS began in 1998.  These same 
advances have profoundly affected the delivery of 
medical care and communication in terrestrial settings, 
as they have in space.  Understanding and designing 
flight medical systems to accommodate current 
information processing standards, and anticipate future 
capabilities, is critical to enabling sufficient medical 




ExMC leverages the history of early spaceflight 
medical systems and current ISS operations to design 
future systems. The progression to greater medical 
capability as well as more robust data management is 
apparent over the course of the US space program. In 
Mercury and Gemini, the medical system consisted of 
select medications and biomonitoring of 
electrocardiograph, blood pressure, respiratory rate, 
galvanic skin resistance, and rectal temperature. These 
measures were monitored by physicians on the ground.  
In Apollo, separate medical kits, consisting primarily 
of medications and bandages, were provided for the 
command and lunar modules.  Skylab carried an 
enhanced medication formulary, resources to support 
some expanded medical capability, and crew with 80 
hours of paramedic-level training.  For Space Shuttle, 
there were several medical kit sub-packs supplied.  
These progressive changes eventually led to today’s 
ISS Crew Health Care System (CHeCS).  CHeCS is 
comprised of three subsystems: Countermeasures 
System (CMS), Environmental Health System (EHS), 
and Health Maintenance System (HMS). CHeCS 
includes monitoring for performance and environment 
as well as medical support for routine medical needs 
and basic and advanced life support for a crew of three 
up to 180 days [9]. 
 
A human mission to Mars is a challenge outside the 
bounds of human experience, but within the grasp of 
our technology and imagination.  It is critical to both 
draw lessons from prior spaceflight experience and to 
recognize the limits of that experience.  Relying too 
heavily on prior spaceflight experience creates a risk 
of not challenging assumptions inapplicable to 
planetary exploration. Each of the earlier medical 
systems was developed for a close-proximity earth-
centred mission that enjoyed the advantages of real-
time telemedical support, consumable resupply, and 
medical evacuation when necessary. Operating outside 
LEO, without access to these advantages, requires a 
closer alignment between vehicle engineering and 
development and medical system development.  
Success in a human Mars mission begins with two key 
drivers: 
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• A comprehensive astronaut healthcare system 
that is mission-enabling 
• A concept of operations that explains how 
such a system will be implemented in an 
exploration mission.   
 
All other design, requirements, and research 
questions will be driven by these two goals.  They form 
the conceptual cornerstone that defines not only the 
system design but also the supporting research 
pathway.  Using operational stakeholders to identify 
requirements for an exploration medical system, an 
applied research program identifies gaps in planned 
operational medical capability and pursues enabling 
research and technology development.  Using this 
framework, ExMC works to: 
 
• Identify envisioned medical needs for a human 
Mars mission. 
• Identify operational barriers to meeting those 
needs. 
• Identify key questions the operational barriers 
raise for meeting medical needs (Capability 
Gaps). 
• Identify applied research goals from the key 
questions. 
• Implement the research pathway recognizing 
agency requirements and stakeholder interests. 
 
Operational requirements for human spaceflight 
are documented in NASA Standard 3001[10].  NASA 
Standard 3001 provides the baseline requirements 
necessary to initiate design of an exploration class 
medical system.  For instance, it requires some level of 
crew medical autonomy be designed into a Mars 
planetary mission. Crew medical autonomy means 
providing the necessary skills and resources to enable 
a desired level of medical capability and flexibility 
without real time terrestrial support.  The prior models 
of planning for medical care relied extensively on 
subject matter expertise to weigh the risks and benefits 
of medical capabilities targeted to the flight constraints 
of the vehicle and mission. For Mars missions, in order 
to balance the risks of under-providing (increased 
medical risk) and over-planning (increased mission 
risk) the medical capability must be viewed as a system 
within the vehicle so that it can be designed in parallel 




Defining a Concept of Operations (ConOps) is a 
critical part of medical system design.  Developing a 
viable ConOps requires two key steps. First, core 
content must be identified, and system needs derived 
from that content.  Operational medical capabilities 
must then be pursued or rejected based on their ability 
to reduce risk and the engineering limitations of the 
expected vehicle and mission.  Second, programmatic 
realities, such as schedule and budget, must be 
addressed to enable system acceptance and support.   
 
Core Content for Exploration Medicine 
 
Concept of Operations for Exploration Medicine 
 
The ExMC ConOps captures the planned operational 
use of the exploration medical system. Specifically, the 
ConOps provides guidance on medical capabilities 
required for prevention, diagnosis, treatment, and 
rehabilitation as envisioned for a Mars Mission to 
enable crew medical autonomy. Critical for Mars 
exploration, individuals will need to be sufficiently 
trained as medical officers, and the exploration 
medical system must be operable at the skill level of 
those selected to serve as medical officers. 
 
The ConOps also envisions and documents both 
planned and unplanned medical activities so that 
capabilities required enable those activities can be 
identified.  This in turn allows ExMC to derive the 
functional requirements and concomitant system 
development and research opportunities.  In areas 
where there is uncertainty, the ConOps aids in the 
identification of gaps that guide the research pathways 
for either an enhanced evidence base or technical 
development.   
 
Risk Assessment Tools and Trade Space 
 
Judicious investments in research capability and 
system design require a quantitative language that is 
understood and agreed upon by both medical and 
engineering personnel designing a given system [5].  
The ability to quantitatively trade in the medical risk 
space is a pre-requisite for making informed decisions 
about the impact on mission medical risk of including 
or excluding specific medical capabilities.  It is also a 
pre-requisite for demonstrating the effects of vehicle 
mass and volume trades on the medical risk posture in 
mission planning.  
 
Planning for unknown medical events presents a 
significant challenge.  Planning and research require a 
metric for medical risk that is measurable in order to 
demonstrate value.  The current system of likelihood 
vs. consequence is limited in the face of medical needs 
because the space of all possible medical issues is 
untenable to list and estimate on evidence-based 
likelihood.  As a result, ExMC uses a strategically 
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chosen subset of conditions to provide a manageable 
approach to likelihood.   
 
Consequence provides a means of assessing the 
expected effectiveness of a medical capability in 
mitigating the effects of a medical condition occurring.  
It is impossible to predict the effectiveness of all 
possible medical treatments given an assumed resource 
set.  It is possible, however, to measure a proposed 
resource set against a defined standard of best practice, 
or a gold standard.  If the gold standard resource set is 
defined as resources available to a U.S.-based tertiary 
care hospital, then the preventive, diagnostic, 
treatment, and rehabilitation capabilities of a proposed 
medical system can be measured against that gold 
standard. This comparison provides a measure of 
medical readiness rather than predictable 
effectiveness.  Since even the relatively unlimited 
capability of a tertiary care hospital cannot provide 
perfect outcomes, medical readiness as measured by 
capability provision is a viable risk metric.   
 
Once quantitative measurements of likelihood and 
medical readiness (as a proxy for consequence) are 
developed, there is value in a modelling approach to 
augment subject matter expert evaluation of these 
complex questions in the medical/engineering domain.  
Probabilistic Risk Analysis (PRA) in the event space 
and a relational database approach to the medical call 
space are discussed here and elsewhere in more detail 
[11].  
 
Medical Data Architecture  
 
Human Mars missions will be severely resource 
limited and the medical system will be reliant on sound 
engineering design. Integration of the CMS and EHS 
systems into the medical system of the ISS 
demonstrate a recognition that the medical system, 
vehicle, and the larger human health and performance 
needs (e.g. nutrition and exercise) are closely tied.  All 
of these systems require the handling of significant 
amounts of information. Data from medical 
monitoring devices must be intelligently combined 
with other monitors (environmental, performance, etc.) 
and designed into the vehicle informatics system.  This 
system must be able to not only collect and process 
data, but also synthesize large amounts of information 
and present it in such a way that the information 
delivered to crew is succinct and relevant.  A Medical 
Data Architecture (MDA) is a core need given the 
massive amounts of information and potential for 
cognitive overload of crew who must be able to 
interpret information and act autonomously.   
 
Knowledge support tools are ubiquitous in 
terrestrial medicine, and augment and refresh medical 
knowledge of physicians practicing on the Earth.  
Terrestrial medicine also has the benefit of immediate 
access to ‘Just in Time’ training videos for medical 
procedures of limited complexity.  Designing to at 
least the level of complexity and information 
processing that is exhibited by most current 
smartphones on earth is a minimum step beyond the 
limitations of the system in place on the ISS.  
Centralizing medically relevant information, 
interfacing with vehicle systems, managing medical 
devices, and providing mirrored information through 
telemetry to mission flight surgeons are all necessary 
functions of an MDA for a human Mars mission.   
 
Medical System Appliance Development 
 
Medical System Appliance development is a 
critical part of the ExMC research pathway that 
naturally flows from the MDA.  ExMC’s ConOps and 
risk assessment define the medical appliances 
desirable for an exploration medical system.  Many 
medical technologies will continue to mature through 
earth-based markets.  It is likely, however, that 
terrestrial technology will have deficiencies in terms of 
mass, volume, power, and system interfaces that will 
need to be addressed through technology development 
processes.  Command and control of medical devices 
(such as ultrasound which is currently used on ISS) 
should be seamless with the shipboard computers as 
should the transfer and storage of medically relevant 
information such as images, device outputs, physician 




Properly assessing research and design requirements 
for exploration medical capabilities requires a new 
ethical framework for the delivery of care.  The 
Institute of Medicine (IOM) found that the “only 
ethically acceptable” option was for NASA to provide 
exceptions to existing standards rather than relaxing 
standards or creating new standards [12]. As a result, 
the ethical framework for exploration will need to 
balance the overall risk of the mission, resource 
constraints, and NASA’s obligation to provide the 
greatest protection practicable for crew.  This balance 
will require the element to clearly identify trade space 
in which medical capabilities will be prioritized: in a 
mass and resource constrained environment, the 
decision to include one capability will force exclusion 
of other capabilities. Further, mission limitations, such 
as communication delays and the inability to return a 
sick or injured crew member to Earth may require real 
time decisions that balance individual care with 
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mission success and broader crew survival. The ethical 
framework, paired with a robust medical risk model, 
should inform these trades.  The Element will 
document significant prioritization decisions; provide 
assumptions, context, and rationale for those 
prioritizations; and seek guidance from the NASA 
Health and Medical Technical Authority (HMTA) and 
bioethicist as appropriate.     
 
 
Figure 2  Ethical Decision Framework proposed by the IOM 
report titled Health Standards for Long Duration and 
Exploration Spaceflight Ethics Principles, Responsibilities, 
and Decision Framework,  [12]. 
 
In addition to clarifying the ethical trade space for 
medical decisions, NASA will also need to address the 
statutory and regulatory framework for the collection 
and use of genetic information.  Personalized medicine 
and pharmacy will be a significant component of an 
effective exploration medical capability. This 
capability cannot be developed without access to 
genetic information on crew.  Currently, the Genetic 
Information Nondisclosure Act (GINA) [13] allows for 
the use of genetic information to develop 
countermeasures for hazards, but there are some 
potential impediments to the collection of data, and 
NASA needs to ensure that sufficient protections are in 
place to prevent the misuse of genetic information in 
prohibited areas such as selection and assignment.   
 
NASA may wish to consider treating all early 
planetary missions as experimental, rather than 
operational [14]. Thus, the crew participating in them 
could be asked to provide an informed consent to those 
risks that exceed the normal operational boundaries 
that have enveloped human flight in LEO. The IOM 
characterized this as ensuring that the crews “exercise 
voluntariness”  [12] For the crew to provide a valid 
consent, each individual would need to presented with 
an individualized risk portrait, based on the best 
available information about the predicted impact of the 
space environment on his or her short and long-term 
health. These risk portraits would contain significant 
uncertainties. The informed consent would also need 
to delineate the perceived scientific and societal value 
of the mission, allowing the individual crew member 
to balance risks and benefits [12].  
 
Finally, in addition to individual risk, NASA must 
assess whether overall mission risk is ethically 
acceptable.  This ethical inquiry will focus on the 
societal benefit of the mission, its urgency, the 
presence of a robust informed consent process for the 
crew, and a commitment to mitigating unavoidable 
harms through the provision of long-term health care 




To enable a useful system scope and research 
pathway, the programmatic needs within the agency 
must be addressed in addition to the technical content.  
The following programmatic needs are critical: 
  
Identify a clear delivery target.  In order to properly 
scope the system and provide a timeline against which 
to measure potential research investments and included 
or excluded capabilities a realistic schedule is required.  
Given the limited resources available, a schedule 
constraint is critical to focus and direct an applied 
research program.   
 
Identify and create ongoing communication pathways 
with stakeholders. Early identification of stakeholders 
is required.  Forward planning to ensure appropriate 
system interface with a future vehicle requires open 
communication pathways with future exploration 
architectural teams as well as engineering teams that 
are responsible for vehicle subsystems.  Creation of a 
ConOps and Risk Analysis tools must reflect 
operational medical experience and crew experience of 
spaceflight needs.   
 
Revise the research pathway as necessary. The applied 
research program pathway for exploration as 
implemented by ExMC must focus on research that 
ultimately informs and supports medical operations in 
an exploration mission.  Prior to this redesign the 
ExMC focus for research was on single-point solutions 
for individual medical issues. These solutions were not 
contextualized or given relative prioritization in the 
context of expected operational need.  In February of 
2014, the Element started this restructuring process to 
approach exploration medical needs from a holistic 
and integrated standpoint.  In this approach, research 
gaps are identified from Core Content above.  Any 
research lines that do not address expected medical 
system needs should be terminated to accommodate 
operationally relevant questions.   
 
Create a means for continuous evaluation of element 
products. An exploration medical system must be 
evaluated from the standpoint of its capacity to provide 
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clinical medical capability and collect data to inform 
an ongoing occupational health model. Clinically 
current medical practitioners are the best judge of 
endpoint clinical utility.  As a result, ExMC stood up 
the Clinician’s Group composed of aerospace 
experienced medical personnel to help guide, assess, 
and develop the ConOps, inform Risk modelling, and 
evaluate research products and system development in 
terms of their clinical utility. This group includes 
representation from Physicians, Nursing, and 
Pharmacy disciplines.  
 
Create a means for systematically identifying and 
managing system interfaces. The inherent complexity 
of an information management system that interfaces 
with a vehicle as well as multiple subsystems required 
to support exploration medical care dictates a highly 
structured, systematic, and disciplined approach.  The 
ExMC Systems Engineering and Integration (SE&I) 
Group is tasked with identifying and negotiating with 
stakeholders and identifying and managing system 
interfaces for the Exploration Medical System 
development.  Needs identified by the SE&I group also 
help prioritize research investments designed to 
increase medical capability and to reduce medical risk 
while minimizing impact to the mission and vehicle.  
 
IV. CURRENT STATUS 
 
Core Content Status 
 
ConOps development starts with the mission of 
interest, a Mars mission, and breaks the mission into 
phases.  First is the Transit Phase to and from Mars 
which identifies system needs for the transfer vehicle.  
Second is the Planetary Phase which identifies system 
needs for the planetary habitat.  Both of these phases 
have an identified sub-phase titled Extravehicular 
Activity (EVA).  EVA activity changes the medical 
risk profile depending on frequency and expected 
exposures.  Each of these phases is further divided into 
functional domains for medicine: planned medical 
events and unplanned medical events. Planned medical 
events allow for decomposition into crew Self-
Directed Care, Crew Medical Officer-Directed Care, 
and Emergency Care domains.   
 
The breakdown in these categories are dictated by two 
principles: 1) respect for crew autonomy in 
symptomatic development (crew members can identify 
and manage small problems and ask for CMO 
assistance when uncertain); and, 2) time available for 
consultation as dependent on a condition and its 
severity (i.e., trauma and bleeding may require care 
and stabilization prior obtaining guidance on 
management from Earth).   
 
The role of ground support in the Exploration 
paradigm is in development.  The current approach 
utilizes a store-and-forward type consultant role for 
earth-based medical support with a system need to 
supply mirrored medical information to earth medical 
support in a near-real-time paradigm. 
 
Medical risk assessment tools have been in 
development for a decade at NASA. The best 
evidence-based model to date is the Integrated Medical 
Model (IMM). The IMM provides a means of merging 
the spaceflight and terrestrial medicine evidence bases 
with Monte Carlo simulation to estimate the 
probability and likelihood of unplanned medical 
conditions [15].  This projection of what medical 
events are likely to occur allows the development of 
baseline needs estimates.  The IMM holds assumptions 
including event type, frequency, and resource 
utilization that are tied to prior human spaceflight 
experience and medical practice. It is critical to 
recognize the model limitations and the model output 
must be interpreted by subject matter experts. 
 
In addition to the IMM, the Medical Optimization 
Network for Space Telemedicine Resources 
(MONSTR) allows trade space analysis for resources 
needed to implement capabilities in the ConOps.  This 
takes the form of a capability ‘wish list’ that a 
terrestrial physician might have. This allows 
deconstruction of unplanned medical needs, starting 
with the Exploration Medical Condition List (EMCL) 
[16].  Deconstruction of the medical capabilities 
desired in the ConOps starts with medical condition in 
the best case or worse case scenario, medical capability 
needed to diagnose or treat, actions required by the 
capability, and finally resources required to implement 
the action.  This allows relational mapping of resources 
common to many conditions to be prioritized above 
rarely used resources; it also allows understanding of 
the impact of inclusion or exclusion of specific 
resources or decisions not to treat on the mass, volume, 
power, and capabilities domains that a system 
entertains.  The prototype version of the MONSTR 
tool had information populated by six board certified 
physicians in Aerospace Medicine, Emergency 
Medicine, Family Medicine, Internal Medicine, and 
Physical Medicine and Rehabilitation. Early 
MONSTR analysis identified the provision of a safe 
and effective pharmacy as the highest priority; this was 
captured in the research pathway as MED02 Pharmacy 
Gap.   
 
The Medical Data Architecture project was initiated 
prior to the completion of the ConOps documents 
because of the long lead-time required to create a 
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relevant software architecture that could provide a 
framework for the information management required 
from the medical system appliances and human and 
environmental monitoring data that is anticipated prior 
to a detailed ConOps delivery.  The relevant focus for 
the initial MDA test bed was drawn from Medical 
Narratives written by the Element Scientist.  Provision 
of a first test bed for evaluation by the Clinician’s 
Group and SE&I Team includes software architecture, 
electronic health records, electrocardiogram, software 
for pharmaceutical reconciliation and research 
tracking, and a prototype biomonitoring system 
developed by the Canadian Space Agency.   
 
This is also the starting point for Medical Appliance 
needs.  Though the ConOps will drive which medical 
appliances are given highest priority, an early need for 
the MDA system is testing the ability to interface with 
a variety of appliances.  This helps elucidate 
engineering and software challenges early in the 
process. An Increment and Iterate approach to the 
development of the MDA/Medical Appliance system 
is planned with roughly yearly deliveries for 
evaluation and feedback that increment the level of 
capability the system supports.   
 
Early test bed evaluation allows opportunities to 
identify software and interface challenges early in the 
design cycle.  Conducting these early tests will also 
help to identify future needs for testing and verification 
and validation that requires continuous SE&I 
involvement and oversight.  As the system matures, 
testing in more challenging analog environments is 
anticipated to stress the system and identify needed 
modifications as early as possible through usage and 
human factors evaluation.  This approach responds to 
Safe Passage Recommendation 3: “using more 
extensively analog environments that already exist and 
that have yet to be developed.” [4].  An initial 
requirement of the project is to provide the capability 
to maximally accept the relevant data and command 
and control interfaces available to optimize the ability 
to draw on Commercial off the Shelf (COTS) 
technologies as they mature through terrestrial market 
utilization.   
 
Finally, the Ethics Pathway is assigned a formal gap in 
the ExMC research structure described below, 
MED06.  Populating the Gap requires more maturity 
of understanding of the system limitations; as a result, 
there is no assigned content at this time.  Content will 
be assigned as the ConOps development dictates a 
need for answers to operationally challenging 
questions and as system-vehicle integration more 
closely identifies the true impact of resource 
limitations on the provision of medical capability.   
 
Current Exploration Medical System Status 
 
The ExMC element is working toward delivery of a 
system for flight testing to the proving ground vehicle 
in 2025 [6].  The proving ground vehicle is a lunar orbit 
testing platform intended to test and demonstrate the 
capabilities required for a Mars Mission.  ExMC chose 
the proving ground vehicle as its target because the 
architecture of the vehicle is sufficiently immature to 
allow delivery of requirements for a medical system 
that can influence vehicle design.  ExMC intentionally 
skipped the Orion vehicle because it is so far along in 
its flight pathway that it is impossible to influence 
central planning from a medical needs standpoint.   
 
The proving grounds vehicle target also helps 
identify early stakeholders within NASA and outside 
of NASA among the international partners who are 
likely to have a role in bringing forth an exploration 
medical system.  Within NASA, these stakeholders 
include the Space Medicine Operations Division, HRP, 
HSRB, the Office of the Chief Medical Officer, and the 
Engineering groups responsible for flight designs and 
hardware such as ECLSS and Avionics.  Stakeholder 
identification and communication is a continuous 
process, and stakeholders amongst the international 
partners include the Canadian Space Agency. Others 
have yet to be identified.    
 
In late 2015, HRP Management reprioritized the 
ExMC research pathway to meet the Core Content 
needs [2].  The first three core content areas discussed 
above form the basis from which all other research 
needs are derived.  ConOps development, Quantitative 
Risk Analysis, and MDA have assigned Gap numbers 
within the ExMC research pathway indicating the need 
to create content and define deliverables.  The content 
areas are assigned MED01, MED08, and MED07 
respectively.  Medical Appliances and Ethics are 
assigned MED13 and MED06 respectively.  The 
numbering is consistent with an organizational strategy 
rather than intellectual primacy.  Given the conceptual 
drivers described above, ExMC research products fall 
into one of three categories: operations research, 
information resources, and technology development. 
This trilogy of research product identification and 
development is modelled after the Department of 
Defence Architecture Framework (DODAF) approach 
[17]. Figure 3 shows these categories with focus within 
the circles and high-level interfaces between the 
domains.  
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Figure 3: ExMC Research Pathway breakdown structure 
by research category with influences shown here.     
ExMC research pathway restructuring used the 
core content needs identified above to identify gaps in 
medical capability to support the creation of the 
exploration medical system. The gaps were 
numerically ordered according to research domain 
(Fig. 4).  Figure 4  lists the Gaps with the breakdown 
of research domains mapped to the corresponding 
relationship and color found in Figure 3.   
 
 
Figure 4: ExMC Research Pathway Gaps.  Gaps 01-06 
fall into the Operational Research Domain, Gaps 07-10 fall 
into the Information Resources Domain, and Gaps 11-13 fall 
into the Technology Development Domain, 
Functionally, these gaps proceed from the ConOps 
and Risk assessment, to prioritize medical capabilities 
to the information resources and technology 
development domains, to products needed to test and 
evaluate an operationally relevant system.  Each of the 
Gaps in this research pathway either influences or is 
influenced by the progress in other Gaps.  This requires 
definition of deliverables from intellectually early 
Gaps to following Gaps.  For example, the medical 
capabilities identified by the ConOps (MED01) 
implies content for a Training Gap (MED05) that must 
be delivered and handled by the MDA (MED07).  The 
content development in the Training Gap (MED05) 
focuses on the following questions: What medical 
training is required and what conditions should it 
address? How do we provide training for those skill 
sets and retention of skills over the long mission 
duration?  How is that training provided by the medical 
system to the crew?  Another example is the influence 
of the ConOps (MED01) on the Pharmacy Gap 
(MED02): what conditions we plan to provide 
treatment for defines what medications are prioritized 
in the provision of a safe and effective pharmacy for 
crews.  Those results then form a starting place for 
understanding which medications are likely to be safe 
and effective throughout the mission and which are 
not.  Those that are prioritized high but are likely to be 
unstable, drive research goals on true shelf life, 
alternatives, or in-mission synthesis options. 
 
V. CONCLUSIONS/ FUTURE WORK 
 
The medical challenges expected in a human Mars 
mission are unlike anything we have experienced in 
prior human spaceflight.  Provision of medical care in 
the face of an inability to resupply materials, inability 
to evaluate sick or injured crewmembers, and the loss 
of real-time telemedical support requires a paradigm 
shift in the planning and research approaches.  This 
work documents the conceptual drivers required to 
reduce medical risk in a Mars exploration mission.   
 
• A paradigm shift in medical planning is 
required to meet the needs of a Mars mission. 
• Vehicle integration of a medical system is a 
requirement of human-centric mission 
planning. 
• A target program/vehicle enables schedule 
creation and acts as a driver for an applied 
research program. 
• Quantitative and modelling approaches to 
medical risk characterization should 
supplement subject matter expert opinions as 
a basis for informed decision making. 
• Sequential approach to research program gap 
development driven by a Concept of 
Operations is critical to program relevancy. 
• Continuous evaluation by clinicians of product 
utility can minimize extraneous research 
expenditures.  
• A systematic and disciplined Systems 
Engineering and Integration approach is the 
cornerstone of medical system development 
and vehicle integration. 
 
These challenges were enumerated and a vision 
proposed in Safe Passage fifteen years ago.  Now with 
the retirement of the ISS approaching and the first 
unmanned flight of the Orion vehicle behind us, we are 
at a point where the transition to a human-centric 
mission architecture must start to become a reality if 
exploration missions are to succeed. Medical system 
requirements and vehicle design must share 
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dependence to minimize the risks to crews.  This 
transition has started but is not yet complete. It coexists 
with a need to cooperate with and share responsibility 
for medical priorities of international partners as 
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